Lepu Medical Technology (Beijing) Co., Ltd. Was established in 1999. Lepu Medical is specializedIn developing, manufacturing and distributing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular, Neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, Cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery With products include coronary stents, dilatation balloon catheters, interventional accessories, Occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro Diagnostic products, critical care products, angiography systems and surgical staplers. In 2009, Lepu Medical went public in ChiNext Shenzhen Stock Exchange market (stock code: 300003).

Now Lepu Medical totally has 32 primary subsidiary companies worldwide. Currently, there are 123 products have received the CE certificates, and 17 products have got the FDA approvals. As The National Interventional Cardiology Medical Instruments & Engineering Technology Research Center, Lepu Medical Group's top strategy is to build up a 4 in 1 platform includes medical devices, Medicines, health services and mobile medicals for cardiac treatments.

Lepu Medical has established three overseas subsidiary companies in Netherland, Turkey and India, Obtained local registrations in 27 countries, and built the sales and distribution channels in over 80 Countries and regions. Lepu Medical upholds "integrity, quality and scientific innovation" as its spirit, Commitments to provide the best quality of products and services to satisfy the needs of healthcare Professionals and patients.